Evidence-based perspective on heart failure and osteoporosis: a systematic review
https://doi.org/10.15829/1560-4071-2023-5306
Abstract
Aim. To study the prognostic relationship between heart failure (HF) and osteoporosis, as well to search for modern principles and approaches to the management of patients.
Material and methods. A search was conducted in the PubMed, RSCI databases from 2012 to 2022 using keywords. The studies were selected according to the PRISMA algorithm.
Results. Based on the results, 124 papers were received, and 9 articles were eventually selected. The age of the patients was at least 49 years (mainly elderly patients). The median follow-up ranged from 12 months to 10,5 years. The larger percentage were females.
Conclusion. Osteoporosis was associated with the HF risk, and patients with heart failure had a higher risk of accidental fracture due to accelerated bone turnover. The foregoing makes it possible to consider patients with HF as a group of increased risk of osteoporosis and associated fractures, and impaired mineral metabolism as a possible additional cardiovascular risk factor.
About the Authors
V. N. Larina
Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Vera N. Larina - MD, PhD, Dr Med. Sc., Professor, Head of Department of outpatient Medicine.
Moscow
Competing Interests:
None
E. S. Shcherbina
Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Ekaterina S. Shcherbina - Resident, Department of Outpatient Medicine.
Moscow
Competing Interests:
None
V. V. Dryutova
Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Valeria V. Dryutova - assistant of the department of Outpatient Medicine.
Moscow
Competing Interests:
None
V. G. Larin
Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Vladimir G. Larin - MD, PhD, Associate Professor, Department of outpatient Medicine.
Moscow
Competing Interests:
None
References
1. Belaya ZE, Belova KYu, Biryukova EV, et al. Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis. Osteoporosis and Bone Diseases. 2021;24(2):4-47. (In Russ.) doi:10.14341/osteo1293.
2. James SL, Lucchesi LR, Bisignano C, et al. The global burden of falls: global, regional and national estimates of morbidity and mortality from the Global Burden of Disease Study 2017. Inj Prev. 2020; 26(suppl 1):i3-i11. doi:10.1136/injuryprev-2019-043286.
3. Fazullina ON, Korbut AI, Dashkin MV, et al. Risk factors for decreased bone mineral density in men with type 2 diabetes. Diabetes mellitus. 2020;23(5):424-33. (In Russ.) doi:10.14341/DM12383.7.
4. Lopatin YuM, Nedogoda SV, Arkhipov MV, et al. Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I. Russian Journal of Cardiology. 2021;26(4):4368. (In Russ.) doi:10.15829/1560-4071-2021-4368.
5. Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14. (In Russ.) doi:10.18087/cardio.2021.4.n1628.
6. Kievit RF, Gohar A, Hoes AW, et al. Queen of Hearts and RECONNECT consortium. Efficient selective screening for heart failure in elderly men and women from the community: a diagnostic individual participant data meta-analysis. Eur J Prev Cardiol. 2018;25:437-46. doi:10.1177/2047487317749897.
7. Skripnikova IA, Yaralieva EK, Drapkina OM. Heart failure and osteoporosis: common pathogenetic components. Cardiovascular Therapy and Prevention. 2022;21(6):3233. (In Russ.) doi:10.15829/1728-8800-2022-3233.
8. Clinical practice guidelines for chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi:10.15829/1560-4071-2020-4083.
9. Bozkurt B, Coats AJ, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Eur J Heart Fail. 2021;23:352-80. doi:10.1002/ejhf.2115.
10. Katano S, Yano T, Tsukada T, et al. Clinical determinants and prognostic impact of osteoporosis in patients with chronic heart failure. Eur Heart J. 2020;41(2):3418. doi:10.1093/ehjci/ehaa946.3418.
11. Chen H, Ye R, Guo X. Lack of causal association between heart failure and osteoporosis: a Mendelian randomization study. BMC Med Genomics. 2022;15:232. doi:10.1186/s12920-022-01385-8.
12. Gu Z, Yuanyuan Y, Lingyu Z, et al. Assessment of the risk of incident heart failure in patients with osteoporosis: a systematic review and meta-analysis of eligible cohort studies. Pol Arch Intern Med. 2020;130(11):934-41. doi:10.20452/pamw.15598.
13. Steinmann E, Brunner-La Rocca HP, Maeder MT, et al. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction? Eur J Intern Med. 2018;57:61-9. doi:10.1016/j.ejim.2018.06.005.
14. Liu XP, Jian XY, Liang DL, et al. The association between heart failure and risk of fractures: Pool analysis comprising 260,410 participants. Front Cardiovasc Med. 2022;9:977082. doi:10.3389/fcvm.2022.977082.
15. Rao MP, Vinereanu D, Wojdyla DM, et al. Apixaban for Reduction in Stroke Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial. Am J Med. 2018;131(3):269-75.e2. doi:10.1016/j.amjmed.2017.10.036.
16. Bowling CB, Sloane R, Pieper C, et al. Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults. J Am Geriatr Soc. 2020;68(9):2059-66. doi:10.1111/jgs.16558.
17. Cosman F, Peterson LR, Towler DA, et al. Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial. J Clin Endocrinol Metab. 2020;105(11):3384-95. doi:10.1210/clinem/dgaa450.
18. Lv F, Cai X, Yang W, et al. Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta-analysis. Bone. 2020;130:115121. doi:10.1016/j.bone.2019.115121.
19. Fujiki S, Kashimura T, Okura Y, et al. Incidence and Risk Factors of Future Need for Long-Term Care Insurance in Japanese Elderly Patients With Left Ventricular Systolic Dysfunction. Circ J. 2021;86(1):158-65. doi:10.1253/circj.CJ-21-0580.
20. Zhou T, Liu P, Dhruva SS, et al. Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019. JAMA Intern Med. 2022;182(2):185-95. doi:10.1001/jamainternmed.2021.7457.
21. Chizhov PA, Ivanova YuI, Medvedeva TV, et al. Osteoporosis of the spine and chronic heart failure. International research journal. 2016;10(52):106-9. (In Russ.) doi:10.18454/IRJ.2016.52.059.
22. Stöhr R, Brandenburg VM, Heine GH, et al. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. Eur J Heart Fail. 2020;22:701-9. doi:10.1002/ejhf.1749.
23. Larina VN, Bart BYa, Karpenko DG, et al. Polymorbidity and its association with the unfavorable course of chronic heart failure in outpatients aged 60 years and older. Kardiologiia. 2019;59(12S):25-36. (In Russ.) doi:10.18087/cardio.n431.
24. Lewiecki EM, Ortendahl JD, Vanderpuye-Orgle J, et al. Healthcare policy changes in osteoporosis can improve outcomes and reduce costs in the United States. JBMR Plus. 2019;3(9):e10192. doi:10.1002/jbm4.10192.
25. van der Burgh AC, de Keyser CE, Zillikens MC, et al. The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density. Drugs. 2021;81(16):1831-58. doi:10.1007/s40265-021-01625-8.
Supplementary files
Review
For citations:
Larina V.N., Shcherbina E.S., Dryutova V.V., Larin V.G. Evidence-based perspective on heart failure and osteoporosis: a systematic review. Russian Journal of Cardiology. 2023;28(3):5306. (In Russ.) https://doi.org/10.15829/1560-4071-2023-5306
Views: 416
Email this article 